Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Johnson Einstein, M.D.

Concepts (141)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms122024110591.220 Why?
Androgen Receptor Antagonists220241140.870 Why?
Terminal Care5201716940.720 Why?
Urogenital Neoplasms120201370.680 Why?
Receptors, Androgen3202310550.680 Why?
Androstenes220191680.670 Why?
Phenylurea Compounds120225280.670 Why?
Compassionate Use Trials12018460.650 Why?
Androgen Antagonists3202413760.640 Why?
Quinolines120227320.590 Why?
Paternalism12016460.560 Why?
Carcinoma, Transitional Cell220218080.530 Why?
Telephone120196170.520 Why?
Carcinoma, Renal Cell4202431420.520 Why?
Death220176780.520 Why?
Kidney Neoplasms3202442600.520 Why?
Advance Directives120162460.480 Why?
Empathy120184740.470 Why?
Physician-Patient Relations5202232290.460 Why?
Personal Autonomy120162980.460 Why?
Cisplatin1201916620.430 Why?
Facial Paralysis120153380.390 Why?
Neoplasm Recurrence, Local5202492390.370 Why?
Vascular Endothelial Growth Factor A2202235100.370 Why?
Sarcoidosis120155060.350 Why?
Urinary Bladder Neoplasms2202122480.350 Why?
Quality of Life22023127880.350 Why?
Immunotherapy4202144370.330 Why?
CD8-Positive T-Lymphocytes2202144770.320 Why?
Internal Medicine1201510090.310 Why?
Cardiopulmonary Resuscitation120159800.290 Why?
Neoplasms62022216750.290 Why?
Internet1201930580.280 Why?
Prostatectomy4202418790.280 Why?
Palliative Care2202134900.270 Why?
Drug Resistance, Neoplasm1202051700.270 Why?
Medical Oncology1201722670.260 Why?
Decision Making2201638870.250 Why?
Leuprolide220243210.220 Why?
Antineoplastic Agents32023136910.210 Why?
Radium12023650.210 Why?
Receptor Tyrosine Kinase-like Orphan Receptors12022420.210 Why?
Thiohydantoins12021200.200 Why?
Attitude of Health Personnel1201538390.190 Why?
Phenylthiohydantoin220191930.190 Why?
Humans3520247438110.180 Why?
Prednisone2202415740.180 Why?
Prostate-Specific Antigen3202424710.170 Why?
Receptors, Vascular Endothelial Growth Factor120226640.160 Why?
Cryosurgery120234530.160 Why?
Tumor Microenvironment2202135830.160 Why?
Male2020243497760.160 Why?
Sickness Impact Profile120193020.150 Why?
Neutropenia120238950.150 Why?
Nitriles220199530.150 Why?
Morbidity1202317680.150 Why?
Benzamides2201913830.140 Why?
Urothelium120192770.140 Why?
Genes, Tumor Suppressor1202110970.140 Why?
Drug Approval120227420.130 Why?
Erythema Nodosum12015300.130 Why?
Lymphocytes, Tumor-Infiltrating1202110380.130 Why?
Internship and Residency1201557870.130 Why?
Serine120188250.120 Why?
Phylogeny1202127960.120 Why?
Soft Tissue Neoplasms1202313630.110 Why?
Renal Insufficiency120198050.110 Why?
Anecdotes as Topic12012570.110 Why?
Antineoplastic Agents, Hormonal1202115230.110 Why?
Angiogenesis Inhibitors1202220370.100 Why?
Sarcoma1202318980.100 Why?
Ambulatory Care Facilities120179340.090 Why?
Neoplasm Invasiveness1201936170.090 Why?
Professional-Patient Relations120167370.090 Why?
Xenograft Model Antitumor Assays1201835470.090 Why?
Hospice Care120176720.090 Why?
Prognosis32020290520.090 Why?
Biopsy1202167500.090 Why?
Survival Analysis22020102510.090 Why?
Virus Diseases120157110.080 Why?
Culture120126320.080 Why?
Positron-Emission Tomography1202462370.080 Why?
Molecular Targeted Therapy1201927270.080 Why?
Gene Expression Regulation, Neoplastic2202084300.070 Why?
Disease Progression12024132730.070 Why?
Neovascularization, Pathologic1201726380.070 Why?
Risk Assessment42021233270.070 Why?
Androgens2202412470.070 Why?
Prevalence12023152110.070 Why?
Melanoma1202455080.070 Why?
Cross-Sectional Studies22023250320.060 Why?
Neoplasm Staging12019110360.060 Why?
Phenotype12021163610.060 Why?
Clinical Trials as Topic1201979080.050 Why?
Longitudinal Studies12019139800.050 Why?
Aged620211631780.050 Why?
Antineoplastic Combined Chemotherapy Protocols22022115240.050 Why?
Age Factors12019183550.050 Why?
Kidney1201771850.050 Why?
Autocrine Communication120221710.050 Why?
United States22022698590.050 Why?
Role120201750.050 Why?
Diagnosis, Differential12015129540.040 Why?
RNA, Double-Stranded120212900.040 Why?
Middle Aged520212132410.040 Why?
Treatment Outcome52024630420.040 Why?
Preoperative Period120215500.040 Why?
Combined Modality Therapy2202186370.040 Why?
Mice, Inbred ICR120183520.040 Why?
Prospective Studies22021532500.040 Why?
Physicians1201645690.040 Why?
Mitosis1202312070.040 Why?
Interferons120217060.040 Why?
beta Catenin1202210600.040 Why?
Salvage Therapy1202312750.030 Why?
Cohort Studies12019405450.030 Why?
Mutation12020297770.030 Why?
Epithelial-Mesenchymal Transition120207130.030 Why?
Perception1202111980.030 Why?
Signal Transduction12017233980.030 Why?
Testosterone1202422970.030 Why?
Feasibility Studies1202350780.030 Why?
Mice, SCID1201827180.030 Why?
Female320173800200.030 Why?
Animals320231686600.030 Why?
Prostate1202017630.030 Why?
Immunologic Factors1202115800.030 Why?
Drug Therapy, Combination1202164870.020 Why?
Neoadjuvant Therapy1202127270.020 Why?
Disease-Free Survival1202068950.020 Why?
Tomography, X-Ray Computed22023201210.020 Why?
Health Status Disparities1202017960.020 Why?
Patient Selection1202042100.020 Why?
Phosphorylation1201884360.020 Why?
Immunohistochemistry12018113600.020 Why?
Genomics1202057140.020 Why?
Cell Line, Tumor12018166740.010 Why?
Adult120152138890.010 Why?
Follow-Up Studies12020390010.010 Why?
Mice12023811540.010 Why?
Retrospective Studies12023774100.010 Why?
Einstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.